Consensus Ingredion Incorporated

Equities

INGR

US4571871023

Market Closed - Nyse 04:00:02 2024-04-26 pm EDT 5-day change 1st Jan Change
113.3 USD -1.04% Intraday chart for Ingredion Incorporated -0.29% +4.39%

Evolution of the average Target Price on Ingredion Incorporated

Price target over the last 5 years

History of analyst recommendation changes

7fc4a84f83a88633.b_lZ1E2ETxchgPPmKm4PLJ774AkCPDlBO2FYXuib3dI.XbUOkT7nJSVN0azXbA9ZRcePtGdVewhzfg0aPIv2vpkowAqwefAnYhjHmA~6f4a1d115ded6655e9a04b7c7404220f
Barclays Raises Ingredion's Price Target to $122 From $115, Maintains Equalweight Rating MT
Goldman Sachs Upgrades Ingredion to Buy From Neutral, Adjusts Price Target to $135 From $122 MT
UBS Adjusts Ingredion Price Target to $138 From $136, Maintains Buy Rating MT
Oppenheimer Adjusts Ingredion Price Target to $125 From $120, Maintains Outperform Rating MT
UBS Adjusts Price Target on Ingredion to $136 From $132, Maintains Buy Rating MT
Oppenheimer Starts Ingredion at Outperform With $120 Price Target MT
BMO Capital Adjusts Price Target on Ingredion to $117 From $125, Keeps Market Perform Rating MT
UBS Adjusts Ingredion Price Target to $135 From $134, Maintains Buy Rating MT
Barclays Trims Price Target on Ingredion to $118 From $120, Maintains Equalweight Rating MT
Stephens Adjusts Ingredion's Price Target to $130 From $120, Keeps Overweight Rating MT
BMO Capital Adjusts Price Target on Ingredion to $123 From $115, Maintains Market Perform Rating MT
Barclays Adjusts Price Target on Ingredion to $120 From $110, Maintains Equalweight Rating MT
UBS Adjusts Ingredion Price Target to $134 From $121, Maintains Buy Rating MT
BMO Capital Reinstates Ingredion at Market Perform With $115 Price Target MT
UBS Upgrades Ingredion to Buy From Neutral, Raises Price Target to $121 From $105 MT
BNP Paribas Exane Consumer Conference FA
Credit Suisse Adjusts Ingredion's Price Target to $110 From $100, Keeps Neutral Rating MT
Barclays Downgrades Ingredion to Equalweight From Overweight, Price Target is $110 MT
UBS Adjusts Ingredion's Price Target to $105 From $93, Maintains Neutral Rating MT
Stephens Upgrades Ingredion to Overweight From Equalweight, Adjusts Price Target to $120 From $100 MT
Credit Suisse Lifts Ingredion's Price Target to $100 From $94, Keeps Neutral Rating MT
UBS Adjusts Ingredion Price Target to $93 From $89, Maintains Neutral Rating MT
UBS Initiates Coverage on Ingredion With Neutral Rating, $89 Price Target MT
Credit Suisse Downgrades Ingredion to Neutral from Outperform, Notes Higher Risk to Margins on Horizon from Rising Corn Input Costs; Lowers PT to $94 from $102 MT
ANALYST RECOMMENDATIONS : AstraZeneca, Blackrock, Nasdaq, Rolls-Royce, Warner Bros Discovery... Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
113.3 USD
Average target price
127 USD
Spread / Average Target
+12.10%
High Price Target
138 USD
Spread / Highest target
+21.81%
Low Price Target
117 USD
Spread / Lowest Target
+3.27%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Ingredion Incorporated

Barclays
Goldman Sachs
UBS
Oppenheimer
BMO Capital
Stephens Inc.
Credit Suisse
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
  1. Stock Market
  2. Equities
  3. INGR Stock
  4. Consensus Ingredion Incorporated